Lets craft your personalized path to looking and feeling your absolute best.
Several studies have shown that a small percentage of people using GLP-1 receptor agonists experience headaches, but even these results are unclear
To meet the needs of semaglutide patients, the FDA allowed compounding pharmacies to manufacture and distribute compounded semaglutide that should be a copy of the branded semaglutide under sections 503A and 503B
An abrupt aversion to sex is a common, albeit lesser-known, complication of taking GLP-1 medications, such as Mounjaro, Wegovy and Ozempic
A provider-guided plan can help reduce risk by reviewing eligibility, sourcing, timing, monitoring, and side effects